Holland Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Holland Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$26.7M	Sell	479,514 -21,712	-4%	-$1.18M	1.17%	40
2017 Q1	$27.3M	Sell	501,226 -49,374	-9%	-$2.71M	1.16%	41
2016 Q4	$32.2M	Buy	550,600 +135,576	+33%	+$7.41M	1.35%	34
2016 Q3	$22.4M	Sell	415,024 -38,989	-9%	-$2.5M	0.92%	46
2016 Q2	$33.4M	Sell	454,013 -391,100	-46%	-$27.6M	1.29%	39
2016 Q1	$54M	Sell	845,113 -11,721	-1%	-$739K	1.43%	32
2015 Q4	$58.9M	Sell	856,834 -27,751	-3%	-$1.83M	1.52%	31
2015 Q3	$52.4M	Sell	884,585 -54,827	-6%	-$3.48M	1.36%	34
2015 Q2	$62.5M	Sell	939,412 -308,698	-25%	-$20.3M	1.49%	34
2015 Q1	$80.5M	Sell	1,248,110 -240,182	-16%	-$15M	1.83%	25
2014 Q4	$87.9M	Sell	1,488,292 -97,592	-6%	-$5.5M	2.01%	20
2014 Q3	$81.2M	Sell	1,585,884 -10,323	-0.6%	-$516K	1.75%	26
2014 Q2	$77.4M	Sell	1,596,207 -27,664	-2%	-$1.36M	1.64%	28
2014 Q1	$84.4M	Sell	1,623,871 -76,243	-4%	-$4.06M	1.83%	26
2013 Q4	$90.4M	Buy	1,700,114 +14,390	+0.9%	+$733K	1.87%	28
2013 Q3	$78M	Buy	1,685,724 +51,144	+3%	+$2.25M	1.81%	27
2013 Q2	$73M	Buy	+1,634,580	New	+$71M	1.84%	24

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Holland Capital Management's BMY Position: Q2 2017 in Review

Holland Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 4.3% in Q2 2017, selling an estimated $1.18M and leaving 479,514 shares worth $26.7M. The position accounts for 1.17% of the portfolio, ranked #40.

Holland Capital Management first reported a position in BMY in Q2 2013 and has held it in 17 quarters since. The position peaked at $90.4M in Q4 2013. 1,595 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

Holland Capital Management held 479,514 shares of Bristol-Myers Squibb worth $26.7M as of Q2 2017.
Holland Capital Management sold 21,712 Bristol-Myers Squibb shares in Q2 2017, an estimated $1.18M.
Bristol-Myers Squibb made up 1.17% of Holland Capital Management's portfolio in Q2 2017, its #40 holding.
Holland Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 17 quarters since.
Holland Capital Management's Bristol-Myers Squibb position peaked at $90.4M in Q4 2013.
1,595 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Holland Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.